Ep 70: Matt Gurney on the use of anti-nerve growth factor drugs in OA management
Nerve growth factor (NGF) is a key player in osteoarthritis (OA) pain transmission and, as a result, anti-NGF drugs (monoclonal antibodies bedinvetmab for dogs and frunevetmab for cats) represent a novel therapeutic target for OA. In this episode, Congress Times editor Tom Jackson speaks to Matt Gurney of Anderson Moores Veterinary Specialists about his early experiences of using this treatment, and how the role of NGF – and the drugs that work against it – is an untapped pathway in OA management. _____________________ 𝗠𝗔𝗧𝗧𝗛𝗘𝗪 𝗚𝗨𝗥𝗡𝗘𝗬 𝗕𝗩𝗦𝗰 𝗖𝗲𝗿𝘁𝗩𝗔 𝗣𝗴𝗖𝗲𝗿𝘁𝗩𝗕𝗠 𝗗𝗶𝗽𝗘𝗖𝗩𝗔𝗔 𝗙𝗥𝗖𝗩𝗦 Matt graduated from…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.